Neuronal protection by bioactive nutrients

International Journal for Vitamin and Nutrition Research

Volumn 78, Issue 6, 2008, Pages 282-285

  Staehelin, Hannes B ^a  

^a Geriatrische Universitatsklinik   (Switzerland)

Author keywords

Alzheimer's disease; Antioxidants; Bioactive nutrients; Cognitive function; Cytokines; Inflammation; Neuronal protection; Omega 3 fatty acids; Prevention

Indexed keywords

AMYLOID PRECURSOR PROTEIN; AMYLOID PROTEIN; ANTIOXIDANT; CYTOKINE; OMEGA 3 FATTY ACID;

AGING; ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; CLINICAL TRIAL; COGNITION; CONFERENCE PAPER; GERIATRIC PATIENT; HUMAN; LONGEVITY; NERVE CELL DEGENERATION; NERVE DEGENERATION; NERVE INJURY; NEUROPROTECTION; NEUROTOXICITY; NUTRIENT; NUTRITION; OBSERVATIONAL STUDY; OXIDATIVE STRESS; PREVALENCE; PROTEIN METABOLISM;

AGED; ALZHEIMER DISEASE; ANTIOXIDANTS; COGNITION; CYTOKINES; DIET THERAPY; FATTY ACIDS, OMEGA-3; HUMANS; NEUROPROTECTIVE AGENTS; PHYTOTHERAPY; PLANT EXTRACTS; RISK FACTORS;

EID: 69549118668     PISSN: 03009831     EISSN: None     Source Type: Journal    
DOI: 10.1024/0300-9831.78.6.282     Document Type: Conference Paper

References (20)

1. Staehelin, H.B. (2005) Promoting Health and Wellbing in Later Life. In: The Cambridge handebook of age and aging. (Johnson, M,. Bengtson, V.L., Colem, N. and Kirkwood, T..B. eds.). pp. 165-177, Cambridge University Press, Cambridge.
2. Selkoe, D.J. (2003) Aging, amyloid, and Alzheimer's disease: a perspective in honor of Carl Cotman. Neurochem Res. 28, 1705-1713. (Pubitemid 37296212)
3. Hardy, J. and Selkoe, D.J. (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 297, 353-356. (Pubitemid 34790756)
4. Hofman, A., Ott, A., Breteler, M.M. et al. (1997) Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet. 349, 151-154. (Pubitemid 27039193)
5. Aliev, G., Smith, M.A., Seyidov, D. et al. (2002) The role of oxidative stress in the pathophysiology of cerebrovascular lesions in Alzheimer's disease. Brain Pathol. 12, 21-35. (Pubitemid 33131359)
6. Engelhart, M.J., Geerlings, M.I., Ruitenberg, A. et al. (2002) Dietary intake of antioxidants and risk of Alzheimer disease. Jama. 287, 3223-3229. (Pubitemid 34686103)
7. Bates, C.J., Benton, D., Biesalski, H.K. et al. (2002) Nutrition and aging: a consensus statement. J Nutr Health Aging. 6, 103-116.
8. Joseph, J.A., Shukitt-Hale, B. and Casdesus, G. (2005) Reversingf the deleterious effects of aging on neuronal-communication and behavior: beneficial effect of fruit polyphenolic compounds. Am J Clin Nutr. 81, 313 s-316 s.
9. Haller, J., Weggemans, R.M., Ferry, M. and Guigoz, Y. (1996) Mental health: minimental state examination and geriatric depression score of elderly Europeans in the SENECA study of 1993. Eur J Clin Nutr. 50 (Suppl 2), S112-116. (Pubitemid 26283332)
10. Perrig, W.J., Perrig, P. and Staehelin, H.B. (1997) The relation between antioxidants and memory performance in the old and very old. J Am Geriatr Soc. 45, 718-724. (Pubitemid 27248781)
11. Morris, M.C., Evans, D.A., Bienias, J.L., Tangney, C.C. and Wilson, R.S. (2002) Vitamin E and cognitive decline in older persons. Arch Neurol. 59, 1125-1132. (Pubitemid 34755825)
12. Seshadri, S., Beiser, A., Selhub, J. et al. (2002) Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Eng.J Med. 346, 476-483. (Pubitemid 34441738)
13. Aisen, P.S., Schneider, L.S., Sano, M. et al. (2008) Highdose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. Jama. 300, 1774-1783.
14. Hwang, E.M.R. Yu, Y.B., Kim, D-G. et al. (2008) BACE1 inhibitory effects of lavandulyl flavanones from Sophora flavescens. Bioorganic&Medicinal Chemistry. 16, 6669-6674.
15. Breitner, J.C. and Zandi, P.P. (2001) Do nonsteroidal drugs reduce the risk of Alzheimer's disease? N Eng.J Med. 345, 1567-1568.
16. (ADAPT) Research Group., Martin, B.K., Szekely, Cet al. (2008) Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial of Naproxen and celecoxib. Arch Neurol. 65, 896-905.
17. Freund-Levi, Y., Eriksdotter-Jonhagen, M., Cederholm, T. et al. (2006) Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Arch Neurol. 63, 1402-1408. (Pubitemid 44547551)
18. Luchsinger, J.A., Tang, M.X., Shea, S. and Mayeux, R. (2002) Caloric intake and the risk of Alzheimer disease. Arch Neurol. 59, 1258-1263. (Pubitemid 34856378)
19. Marx, J. (2007) Alzheimer's disease. A new take on tau. Science. 316, 1416-1417.
20. McCann, J.C. and Ames, B.N. (2008) Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction? Faseb J. 22, 982-1001.